1. Home
  2. RPGL vs IBIO Comparison

RPGL vs IBIO Comparison

Compare RPGL & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RPGL

Republic Power Group Limited Class A Ordinary Shares

N/A

Current Price

$2.41

Market Cap

74.0M

Sector

Technology

ML Signal

N/A

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$1.88

Market Cap

72.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPGL
IBIO
Founded
2015
2008
Country
Singapore
United States
Employees
8
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.0M
72.2M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
RPGL
IBIO
Price
$2.41
$1.88
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.75
AVG Volume (30 Days)
4.5M
672.8K
Earning Date
05-16-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.56
52 Week High
$13.06
$3.82

Technical Indicators

Market Signals
Indicator
RPGL
IBIO
Relative Strength Index (RSI) 47.53 51.76
Support Level $0.31 $1.70
Resistance Level $8.44 $2.00
Average True Range (ATR) 1.62 0.17
MACD 0.08 0.03
Stochastic Oscillator 16.97 64.25

Price Performance

Historical Comparison
RPGL
IBIO

About RPGL Republic Power Group Limited Class A Ordinary Shares

Republic Power Group Ltd is a provider of customized ERP software solutions, consulting and technical support services, and peripheral hardware to corporate clients and government agencies, including airports, cruise terminals, and technology, trading, and logistics companies. The Company operates from Singapore and has historically served clients in Singapore and Malaysia, offering ERP systems with functions such as accounting, procurement, workflow automation, real-time monitoring, and capabilities including planning, surveillance, and threat detection. The Company leverages artificial intelligence and modular algorithms to address complex operational requirements and integrates sensors, controls, and other hardware to enable IoT connectivity with autonomous or semiautonomous outcomes.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: